Australia's Vita Life Sciences hits over 4-1/2-yr high on upbeat H1 outlook

Vita Life Sciences

28/05/2021 06:46

** Shares of Vita Life Sciences  VLS.AX  rise as much as
24.5% to A$1.22, their highest since Oct 26, 2016
    ** Co sees its H1 2021 sales to be between A$23.5 mln to
A$24.5 mln($18.18 mln - $18.96 mln) compared to A$22 mln in H1
2020  urn:newsml:reuters.com:*:nASX1DlKV8
    ** VLS sees H1 2021 Pre-tax Profit in range of A$4.0 mln to
A$4.5 mln versus A$4.2 mln in H1 2020 
    ** Co appoints Henry Townsing as non-executive chairman
effective May 28  urn:newsml:reuters.com:*:nFWN2NE189
    ** Stock posts its biggest intraday percentage gain since
Aug 21, 2020
    ** About 183,000 shares change hands compared to the 30-day
average volume of about 20,000 shares
    ** VLS down 2% this year as of last close

       


($1 = 1.2923 Australian dollars)

 (Reporting by Aditya Munjuluru in Bengaluru)
 ((aditya.srivastsav@thomsonreuters.com))